Integrated Analysis of Multiple Biomarkers from Circulating Tumor Cells Enabled by Exclusion-Based Analyte IsolationJamie M. Sperger, Joshua M. Lang, Lindsay N. Strotman et al.|Clinical Cancer Research|2016Cited by 70
Selective Nucleic Acid Removal via Exclusion (SNARE): Capturing mRNA and DNA from a Single SampleLindsay N. Strotman, David J. Beebe, Rachel O’Connell et al.|Analytical Chemistry|2013Cited by 45
Abstract 4816: Development of an integrated analysis platform of circulating melanoma cells for PD-L1 expression as a predictive biomarkerBenjamin K. Gibbs, Joshua M. Lang, Lindsay N. Strotman et al.|Cancer Research|2014Cited by 0
Molecular analysis of antigen presentation machinery in circulating tumor cells from renal cell carcinoma and prostate cancerJoshua M. Lang, David J. Beebe, Jacob T Tokar et al.|Journal for ImmunoTherapy of Cancer|2013Cited by 0
Abstract 1602: Development and validation of an NGS-based assay to detect all classes of genomic alterations in circulating tumor cells (CTCs) from patients with solid tumorsAllison W. Welsh, Philip J. Stephens, Garrett M. Frampton et al.|Cancer Research|2015Cited by 0